Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

 Zantac 75 EFFERdose (Ranitidine Hydrochloride) Effervescent Tablets
Company:  Glaxo Wellcome Inc.
Application No.:  020745
Approval Date: 2/26/1998


Date created: May 17, 2005

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.